Recently added
This page was added on 04 June 2018.
Updates made
This page was updated on [date-counter-updated-date]. View history of updates
Sponsor
GlaxoSmithKline Australia
Administration route
Intramuscular injection
Vaccine group
Combination vaccines
Description:
Registered for use in children aged 1–15 years.
Hepatitis A and hepatitis B vaccine combination vaccine.
Each 0.5 mL monodose vial or pre-filled syringe contains:
- 360 ELISA units of inactivated hepatitis A virus (HM175 strain)
- 10 µg recombinant hepatitis B surface antigen protein
- 0.225 mg aluminium as aluminium phosphate and aluminium hydroxide
Also contains traces of:
- formaldehyde
- neomycin
- trometamol
- polysorbate 20
May contain yeast proteins.
For Product Information and Consumer Medicine Information about Twinrix (360/10) visit the Therapeutic Goods Administration website.
Additional vaccine information
For detailed advice on vaccine dosage, administration, contraindications and precautions, and variations from product information, please visit the relevant disease chapter/s.
Allergy advice
May contain yeast proteins.
Related diseases
Page history
Last updated
Last reviewed